NY-HANSHOW
16.1.2023 15:01:38 CET | Business Wire | Press release
Hanshow participated in the 2023 National Retail Federation (NRF), the largest retail event in the world. At this year’s NRF Exhibition Booth, Hanshow unveiled a new generation protocol high-density low-power cellular network (HiLPC) and four-color Electronic Shelf Label (ESL). Hanshow has strengthened the operability of both its hardware and software and now provides more advanced solutions and services for the digital upgrading of retail industry customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230111005732/en/
Hanshow's new generation protocol high-density low-power cellular network (HiLPC) (Graphic: Business Wire)
Rapid upgrading that is more than just “fast”
Hanshow already provided the world’s leading series of ESL products, and this advanced performance has been further improved through Hanshow’s new generation HiLPC. With HiLPC innovative system architecture, the communication speed of the ESL is greatly improved, and the update speed can reach over 60,000 pieces/hour/ESL controller, making it quicker and easier to install and bind. The super-high system throughput of the HiLPC enables updating tens of millions of devices within a few minutes, which brings clients a totally novel experience of real-time ESL services and enhances clients’ capability of managing globally distributed stores.
With this upgraded protocol, Hanshow ESL Solution enables batch, timed, and synchronized task updates in the same store with errors controlled at the millisecond level, and it can also synchronize dynamic price changes, realize precise timing synchronization while online and even offline, and track the position of products, greatly improving the operational efficiency of stores.
The new generation HiLPC makes it possible to nomadically update ESLs, which opens opportunities for new industrial applications. It also supports flashing light prompts for any number of goods being selected to help employees quickly find the location of goods for sorting. It supports dynamic network resource allocation used in conjunction with Wi-Fi, solving the network incompatibility challenges. In addition, the new generation protocol combined with ESL controllers and financial-grade security chips provides the most reliable data protection available.
Breaking through with smarter and better performance
Hanshow also unveiled the four-color ESL product series that supports black, white, red, and yellow color displays in any combination, expanding the digital display possibilities for retailers. This product’s screen updating and flashing speeds are significantly optimized compared with previous models, especially in conjunction with the new generation HiLPC.
In addition to the breakthrough in vivid displays, Hanshow has focused on increasing its precision applications for specific industry demands. Hanshow’s thermal detector and DIY ESL solutions are designed to help retailers solve special applications for temperature monitoring and automatic temperature change alerts, as well as the product use adaptation problems of home improvement retail and other business forms.
For years, Hanshow has pursued continuous innovation based on customer needs and remained committed to enabling customers to achieve upgrading for better operational efficiency. The new generation HiLPC and four-color ESL directly achieve this by drastically reducing the energy supply and paper materials needed to operate a physical store. In the future, Hanshow will continue developing innovative digital technology, fully assist customers in digital upgrading, and create a green, leading, and sustainable digital new experience in the industry.
About Hanshow
Hanshow is a global leader in developing and manufacturing electronic shelf labels and digital store solutions, offering global customers a series of world-class customized IoT touchpoints and digital store solutions that deliver customer-centric insights. Hanshow’s solutions are used by over 30,000 stores in more than 50 countries, helping retailers streamline operations, optimize pricing strategies, and offer consumers a more personalized experience. Learn more: www.hanshow.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230111005732/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 12:00:00 CET | Press release
Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 11:40:00 CET | Press release
Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amo
NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 11:00:00 CET | Press release
NIQ’s new solution brings unprecedented clarity into package types, materials, and true consumption across markets, closing critical industry gaps NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding
European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 08:47:00 CET | Press release
European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
